Terrie Curran - 09 Sep 2021 Form 4 Insider Report for Myovant Sciences Ltd.

Role: Director
Signature: /s/ Matthew Lang, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 09 Sep 2021
Net transactions value: -$86,960
Form type: 4
Filing time: 13 Sep 2021, 16:11:39 UTC
Previous filing: 03 Sep 2021
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYOV	Common Shares	Options Exercise	$37,102	+4,850		$7.65	4,850	09 Sep 2021	Direct
transaction	MYOV	Common Shares	Sale	$124,063	-4,850	-100%	$25.58	0	09 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MYOV	Stock Option (Right to Buy)	Options Exercise	$0	-4,850	-48%	$0.000000	5,250	09 Sep 2021	Common Shares	4,850	$7.65	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold pursuant to a 10b5-1 trading plan.
F2	The shares were sold at prices ranging from $25.42 to $25.72. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	Fully vested.